Clinical Trials Browser

Phase 2/3 × Withdrawn × Paclitaxel × Clear all

NCT02272699 2021-03-18

Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma

Phase 2/3 Withdrawn

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02651610 2017-07-11

Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer

Phase 2/3 Withdrawn

Breast Neoplasms